PACB - Pacific Biosciences of California - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PACB is currently covered by 5 analysts with an average price target of $1.92. This is a potential downside of $0.14 (-6.8%) from yesterday's end of day stock price of $2.06.

Pacific Biosciences of California's activity chart (see below) currently has 144 price targets and 130 ratings on display. The stock rating distribution of PACB is 40% BUY, 40% HOLD and 20% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 62.71% with an average time for these price targets to be met of 217.27 days.

Highest price target for PACB is $3, Lowest price target is $1.35, average price target is $1.92.

Most recent stock forecast was given by DOUG SCHENKEL from WOLFE on 09-Sep-2026.

Best performing analysts who are covering PACB - Pacific Biosciences of California:

Kyle Mikson Bryan Brokmeier Sung Ji Nam William Quirk Drew Jones Ross Osborn Doug Schenkel

Currently out of the existing stock ratings of PACB, 4 are a BUY (40%), 4 are a HOLD (40%), 2 are a SELL (20%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 04-Jan-2019

$1.35

$-0.38 (-21.97%)

1 months 14 days ago
(09-Sep-2026)

3/3 (100%)

$0.06 (4.65%)

131

Sell Since 14-Apr-2026

$1.5

$-0.15 (-9.09%)

$1

5 months 12 days ago
(11-May-2026)

5/8 (62.5%)

$0.14 (10.29%)

25

Buy Since 01-Jun-2020

$3

$1.27 (73.41%)

$3

7 months 4 days ago
(19-Mar-2026)

7/19 (36.84%)

$1.6 (114.29%)

133

Hold Since 16-May-2022

$2

$0.35 (21.21%)

$1.5

11 months 12 days ago
(11-Nov-2025)

13/14 (92.86%)

$0.14 (7.53%)

98

Buy Since 18-Feb-2025

$2

$0.35 (21.21%)

$1.8

11 months 13 days ago
(10-Nov-2025)

3/3 (100%)

$0.24 (13.64%)

150

Show more analysts

Please expand the browser size to see the chart

What is PACB (Pacific Biosciences of California) average time for price targets to be met?

On average it took 217 days for the stock forecasts to be reached, with an average price target met ratio of 62.71%.

Which analyst most recently updated their price target on PACB (Pacific Biosciences of California)?

Doug Schenkel

Which analyst has the most public recommendations on PACB (Pacific Biosciences of California)?

Doug Schenkel works at UBS and has 13 price targets and 10 ratings on PACB

Which analyst is the currently most bullish on PACB (Pacific Biosciences of California)?

Steven Mah with the highest potential upside of $50.27

Which analyst is the currently most reserved on PACB (Pacific Biosciences of California)?

Doug Schenkel with the lowest potential downside of -$0.38
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?